Download PDF
AJP Rep 2012; 02(01): 029-032
DOI: 10.1055/s-0032-1305797
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Successful Treatment of a Neonate with Idiopathic Persistent Pulmonary Hypertension with Inhaled Nitric Oxide via Nasal Cannula without Mechanical Ventilation

Jayasree Nair
1   Division of Neonatology, Women and Children's Hospital of Buffalo, State University of New York at Buffalo, Buffalo, New York
,
Joseph Orie
2   Pediatric Cardiology Associates, Buffalo, New York
,
Satyan Lakshminrusimha
1   Division of Neonatology, Women and Children's Hospital of Buffalo, State University of New York at Buffalo, Buffalo, New York
› Author Affiliations
Further Information

Publication History

26 August 2011

18 November 2011

Publication Date:
22 February 2012 (online)

   Permissions and Reprints

Abstract

We report a case study of a term neonate presenting with oxygen desaturation without respiratory distress or acidosis, despite receiving 100% oxygen through a nasal cannula. Echocardiogram showed evidence of persistent pulmonary hypertension of the newborn (PPHN). She was successfully treated with inhaled nitric oxide (iNO) via nasal cannula without requiring mechanical ventilation. In a term neonate with idiopathic PPHN with adequate respiratory drive without any parenchymal lung disease, noninvasive methods of iNO delivery may treat the condition without the complications associated with mechanical ventilation.

Keywords

hypoxemic respiratory failure - noninvasive ventilation
 

  • References

  • 1 Konduri GG, Kim UO. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 2009; 56: 579-600
    CrossrefPubMedGoogle Scholar
  • 2 Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819
    CrossrefPubMedGoogle Scholar
  • 3 Davidson D, Barefield ES, Kattwinkel J , et al; The I-NO/PPHN Study Group. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998; 101 (3 Pt 1) 325-334
    Google Scholar
  • 4 The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597-604
    CrossrefPubMedGoogle Scholar
  • 5 Clark RH, Kueser TJ, Walker MW , et al; Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000; 342: 469-474
    CrossrefPubMedGoogle Scholar
  • 6 Leavitt AM, Watchko JF, Bennett FC, Folsom RC. Neurodevelopmental outcome following persistent pulmonary hypertension of the neonate. J Perinatol 1987; 7: 288-291
    PubMedGoogle Scholar
  • 7 Kinsella JP, Parker TA, Ivy DD, Abman SH. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr 2003; 142: 397-401
    CrossrefPubMedGoogle Scholar
  • 8 Alano MA, Ngougmna E, Ostrea Jr EM, Konduri GG. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001; 107: 519-523
    CrossrefPubMedGoogle Scholar
  • 9 Hayes Jr D, Feola DJ, Murphy BS, Shook LA, Ballard HO. Pathogenesis of bronchopulmonary dysplasia. Respiration 2010; 79: 425-436
    CrossrefPubMedGoogle Scholar
  • 10 Miller JD, Carlo WA. Pulmonary complications of mechanical ventilation in neonates. Clin Perinatol 2008; 35: 273-281 , x–xi
    Google Scholar
  • 11 Ivy DD, Wiggins JW, Badesch DB, Kinsella JP, Kelminson LL, Abman SH. Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension. Am J Cardiol 1994; 74: 414-416
    CrossrefPubMedGoogle Scholar
  • 12 Kakuya F, Takase M, Ishii N , et al. Inhaled nitric oxide therapy via nasopharyngeal tube in an infant with end-stage pulmonary hypertension. Acta Paediatr Jpn 1998; 40: 155-158
    CrossrefPubMedGoogle Scholar
  • 13 Channick RN, Newhart JW, Johnson FW , et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 1996; 109: 1545-1549
    CrossrefPubMedGoogle Scholar
  • 14 Ballard RA, Truog WE, Cnaan A , et al; NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355: 343-353
    CrossrefPubMedGoogle Scholar
  • 15 Ivy DD, Parker D, Doran A, Parker D, Kinsella JP, Abman SH. Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. Am J Cardiol 2003; 92: 886-890
    CrossrefPubMedGoogle Scholar
  • 16 Ambalavanan N, St John E, Carlo WA, Bulger A, Philips III JB. Feasibility of nitric oxide administration by oxygen hood in neonatal pulmonary hypertension. J Perinatol 2002; 22: 50-56
    CrossrefPubMedGoogle Scholar
  • 17 Ambalavanan N, El-Ferzli GT, Roane C, Johnson R, Carlo WA. Nitric oxide administration using an oxygen hood: a pilot trial. PLoS ONE 2009; 4: e4312
    CrossrefPubMedGoogle Scholar